Thursday morning snapshot

A snapshot of the early morning's equity news and key market movements.

Last night in the US: The Dow Jones closed down 61 points at 15,618, the NASDAQ finished down 21 points at 3930 and the S&P 500 ended the day down eight points at 1763.

This morning in London: The FTSE 100 is currently down 15 points at 6760.

FX and commodities: GBP/USD is down 21 pips at $1.6018,,EUR/USD is 39 pips weaker at $1.3696 and USD/JPY is 10 pips lower at ¥98.32. Brent crude is down 36 cents at $109.52 and gold  $6.15 lower at $1336,.

Latest news: Even though the US Federal Reserve kept its $85 billion monthly stimulus package in place, the accompanying comments were no more downbeat than in September, which considering the recent poor US economic data was perhaps slightly surprising.

Stocks: Astrazeneca continues to struggle, recording lower sales and profit. Croda International has seen a mild uptick in Q3 sales, and BT Group continues to see a steady stream of consumers subscribe to its sports package, with the total now standing at two million.

The day ahead: The Nationwide monthly house price index has once again risen by 1%. At 10am the latest EU unemployment rate is released, followed by US unemployment claims this afternoon.

All figures correct at 8.15am. All times London time.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.